Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Health and Quality of Life Outcomes|September 6, 2014
Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systemsMarc Miravitlles, Alicia Huerta, José Alberto Fernández-Villar, et al.Health and Quality of Life Outcomes|December 7, 2010
Validation of a computer-adaptive test to evaluate generic health-related quality of lifePablo Rebollo, Ignacio Castejón, Jesús Cuervo, et al.European Heart Journal. Quality of Care & Clinical Outcomes|January 17, 2019
Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register dataMaria Lindh, Jonas Banefelt, Kathleen M Fox, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 4, 2019
Comparison of Recommendations and Use of Cardiovascular Risk Equations by Health Technology Assessment Agencies and Clinical GuidelinesMarissa Blieden Betts, Sandra Milev, Meredith Hoog, et al.Pharmacoeconomics|December 9, 2016
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin LymphomaKelly Fust, Xiaoyan Li, Michael Maschio, et al.Journal of Medical Economics|March 25, 2018
Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspectiveRichard B Lipton, Alan Brennan, Stephen Palmer, et al.Clinical Therapeutics|April 4, 2017
Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in SpainGuillermo Villa, Mickael Lothgren, Lucie Kutikova, et al.European Heart Journal. Quality of Care & Clinical Outcomes|October 16, 2020
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in SwedenUlf Landmesser, Peter Lindgren, Emil Hagström, et al.Plos One|August 2, 2021
Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort studyJean Ferrières, Victoria Banks, Demetris Pillas, et al.Advances in Therapy|June 11, 2022
Achieving Lower LDL-C Levels After a Recent Myocardial Infarction Might Be Associated with Lower Healthcare Resource Use and Costs in SpainCarlos Escobar-Cervantes, Guillermo Villa, Ignasi Campos-Tapias, et al.Pageof 5